Long-term mortality after community-acquired pneumonia - Impacts of diabetes and newly discovered hyperglycaemia: A prospective, observational cohort study

BMJ Open

Volumn 4, Issue 8, 2014, Pages

  Koskela, Heikki O ^a,b   Salonen, Päivi H ^a   Romppanen, Jarkko ^c   Niskanen, Leo ^b,d  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c OK Kuopio   (Finland)

^d Finnish Medicines Agency Fimea ^*  (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; GLUCOSE BLOOD LEVEL; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76); UREA;

ADULT; AGED; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD OXYGEN TENSION; CAUSE OF DEATH; CHRONIC RESPIRATORY TRACT DISEASE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; DIABETES MELLITUS; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; FEMALE; FINLAND; FOLLOW UP; GLUCOSE BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SURVIVAL RATE; SURVIVOR; BLOOD; COMMUNITY-ACQUIRED INFECTIONS; LENGTH OF STAY; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PNEUMONIA; PROPORTIONAL HAZARDS MODEL;

AGED; BLOOD GLUCOSE; C-REACTIVE PROTEIN; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; DIABETES MELLITUS; FEMALE; FINLAND; HUMANS; HYPERGLYCEMIA; LENGTH OF STAY; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PNEUMONIA; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; UREA;

EID: 84922380532     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-005715     Document Type: Article

References (27)

1. World Health Organization. The top 10 causes of death 2011. Secondary The top 10 causes of death 2011 2013. http://who.int/mediacentre/factsheets/fs310/ en/ (access 16 May 2014).
2. Johnstone J, Eurich DT, Majumdar SR, et al. Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study. Medicine (Baltimore) 2008;87:329-34.
3. Koivula I, Sten M, Makela PH. Prognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up study. Arch Intern Med 1999;159:1550-5. (Pubitemid 29340308)
4. Kaplan V, Clermont G, Griffin MF, et al. Pneumonia: still the old man's friend? Arch Intern Med 2003;163:317-23. (Pubitemid 36183860)
5. Bruns AH, Oosterheert JJ, Cucciolillo MC, et al. Cause-specific long-term mortality rates in patients recovered from community-acquired pneumonia as compared with the general Dutch population. Clin Microbiol Infect 2011;17:763-8.
6. Ewig S, Torres A. Community-acquired pneumonia as an emergency: time for an aggressive intervention to lower mortality. Eur Respir J 2011;38:253-60.
7. Restrepo MI, Faverio P, Anzueto A. Long-term prognosis in community-acquired pneumonia. Curr Opin Infect Dis 2013;26:151-8.
8. Mortensen EM. Potential causes of increased long-term mortality after pneumonia. Eur Respir J 2011;37:1306-7.
9. Yende S, van der Poll T, Lee M, et al. The influence of pre-existing diabetes mellitus on the host immune response and outcome of pneumonia: analysis of two multicentre cohort studies. Thorax 2010;65:870-7.
10. Kinzel T, Smith M. Hyperglycemia as a predictor for mortality in veterans with pneumonia. Exp Aging Res 1988;14:99-102. (Pubitemid 19050436)
11. McAlister FA, Majumdar SR, Blitz S, et al. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care 2005;28:810-15. (Pubitemid 40434478)
12. Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet 2009;373:1798-807.
13. Rueda AM, Ormond M, Gore M, et al. Hyperglycemia in diabetics and non-diabetics: effect on the risk for and severity of pneumococcal pneumonia. J Infect 2010;60:99-105.
14. Lepper PM, Ott S, Nuesch E, et al. Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study. BMJ 2012;344: e3397.
15. Karnofsky DA, Burchenal JH. The clinical evaluation of chemoterapeutic agents in cancer. In: Macleod CM, ed. Evaluation of chemoterapeutic agents. New York: Columbia University Press, 1949:191-205.
16. Yates JW, Chalmer B, McKegney FP. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 1980;45:2220-4. (Pubitemid 10150440)
17. Salonen PH, Koskela HO, Niskanen L. Prevalence and determinants of hyperglycaemia in pneumonia patients. Scand J Infect Dis 2013;45:88-94.
18. Kruger S, Papassotiriou J, Marre R, et al. Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ. Intensive Care Med 2007;33:2069-78. (Pubitemid 350164580)
19. Januzzi JL, van Kimmenade R, Lainchbury J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 2006;27:330-7. (Pubitemid 43100029)
20. Gerich J. Pathogenesis and management of postprandial hyperglycemia: role of incretin-based therapies. Int J Gen Med 2013;6:877-95.
21. American Diabetes Association. Standards of medical care in diabetes - 2013. Diabetes Care 2013;36:S11-66.
22. Noble D, Mathur R, Dent T, et al. Risk models and scores for type 2 diabetes: systematic review. BMJ 2011;343:d7163.
23. Koskela HO, Salonen PH, Niskanen L. Hyperglycaemia during exacerbations of asthma and chronic obstructive pulmonary disease. Clin Respir J 2013;7:382-9.
24. National Statistical Service of Finland. The causes of death 2012. https://tilastokeskus.fi/til/ksyyt/2012/ksyyt-2012-2013-12-30-tie-001-fi.html (access 16 May 2014).
25. Farr BM, Sloman AJ, Fisch MJ. Predicting death in patients hospitalized for community-acquired pneumonia. Ann Intern Med 1991;115:428-36.
26. Blasi F, Mantero M, Santus P, et al. Understanding the burden of pneumococcal disease in adults. Clin Microbiol Infect 2012;18:7-14.
27. National Care Guidelines Group: Treatment of pneumonia [Finnish]. Duodecim 2008;124:2030-9.